Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 219

1.

Discovery of velpatasvir (GS-5816): A potent pan-genotypic HCV NS5A inhibitor in the single-tablet regimens Vosevi® and Epclusa®.

Link JO, Taylor JG, Trejo-Martin A, Kato D, Katana AA, Krygowski ES, Yang ZY, Zipfel S, Cottell JJ, Bacon EM, Tran CV, Yang CY, Wang Y, Wang KW, Zhao G, Cheng G, Tian Y, Gong R, Lee YJ, Yu M, Gorman E, Mogalian E, Perry JK.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2415-2427. doi: 10.1016/j.bmcl.2019.04.027. Epub 2019 May 4.

PMID:
31230974
2.

Discovery of the pan-genotypic hepatitis C virus NS3/4A protease inhibitor voxilaprevir (GS-9857): A component of Vosevi®.

Taylor JG, Zipfel S, Ramey K, Vivian R, Schrier A, Karki KK, Katana A, Kato D, Kobayashi T, Martinez R, Sangi M, Siegel D, Tran CV, Yang ZY, Zablocki J, Yang CY, Wang Y, Wang K, Chan K, Barauskas O, Cheng G, Jin D, Schultz BE, Appleby T, Villaseñor AG, Link JO.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2428-2436. doi: 10.1016/j.bmcl.2019.03.037. Epub 2019 Mar 26.

PMID:
31133531
3.

Baccharis trimera (Carqueja) Improves Metabolic and Redox Status in an Experimental Model of Type 1 Diabetes.

do Nascimento Kaut NN, Rabelo ACS, Araujo GR, Taylor JG, Silva ME, Pedrosa ML, Chaves MM, Rossoni Junior JV, Costa DC.

Evid Based Complement Alternat Med. 2018 Dec 4;2018:6532637. doi: 10.1155/2018/6532637. eCollection 2018.

4.
5.

Student perceptions of an experiential education clinic within a pharmacy school.

Lysak K, Berenbaum SL, Landry EJ, Mulhall SM, Perepelkin JP, Shevchuk YM, Taylor JG, Jorgenson DJ.

Curr Pharm Teach Learn. 2018 Dec;10(12):1636-1640. doi: 10.1016/j.cptl.2018.09.001. Epub 2018 Sep 12.

PMID:
30527831
6.

Establishing a national sickle cell disease program in the Republic of Congo.

Dokekias AE, Ngolet L, Salomon-Andonie J, Nekhai S, Taylor JG 6th.

Blood Adv. 2018 Nov 30;2(Suppl 1):17-18. doi: 10.1182/bloodadvances.2018GS111084. No abstract available.

7.

Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.

Coelho GS, Andrade JS, Xavier VF, Sales Junior PA, Rodrigues de Araujo BC, Fonseca KDS, Caetano MS, Murta SMF, Vieira PM, Carneiro CM, Taylor JG.

Chem Biol Drug Des. 2019 Mar;93(3):337-350. doi: 10.1111/cbdd.13420. Epub 2018 Nov 27.

PMID:
30362274
8.

Cunaniol-elicited seizures: Behavior characterization and electroencephalographic analyses.

Hamoy M, Dos Santos Batista L, de Mello VJ, Gomes-Leal W, Farias RAF, Dos Santos Batista P, do Nascimento JLM, Marcondes HC, Taylor JG, Hutchison WD, Torres MF, Barbas LAL.

Toxicol Appl Pharmacol. 2018 Dec 1;360:193-200. doi: 10.1016/j.taap.2018.10.008. Epub 2018 Oct 5.

PMID:
30296455
9.

Survey of Living Organ Donors' Experience and Directions for Process Improvement.

Li T, Dokus MK, Kelly KN, Ugoeke N, Rogers JR, Asham G, Sharma VA, Cirillo DJ, Robinson MK, Venniro EK, Taylor JG, Orloff MS, McIntosh S, Kashyap R.

Prog Transplant. 2017 Sep;27(3):232-239. doi: 10.1177/1526924817715467. Epub 2017 Jul 4.

PMID:
29187096
10.

Characterization of HCV resistance from a 3-day monotherapy study of voxilaprevir, a novel pangenotypic NS3/4A protease inhibitor.

Lawitz E, Yang JC, Stamm LM, Taylor JG, Cheng G, Brainard DM, Miller MD, Mo H, Dvory-Sobol H.

Antivir Ther. 2018;23(4):325-334. doi: 10.3851/IMP3202.

PMID:
29063860
11.

Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia.

Darbari DS, Vaughan KJ, Roskom K, Seamon C, Diaw L, Quinn M, Conrey A, Schechter AN, Haythornthwaite JA, Waclawiw MA, Wallen GR, Belfer I, Taylor JG 6th.

Scand J Pain. 2017 Oct;17:279-286. doi: 10.1016/j.sjpain.2017.08.001. Epub 2017 Sep 30.

12.

Prostacyclin-analog therapy in sickle cell pulmonary hypertension.

Weir NA, Saiyed R, Alam S, Conrey A, Desai HD, George MP, Keeley JH, Klings ES, Mehari A, Taylor JG 6th, Minniti CP, Kato GJ.

Haematologica. 2017 May;102(5):e163-e165. doi: 10.3324/haematol.2015.131227. Epub 2017 Jan 25. No abstract available.

13.

London Hybrid Exposure Model: Improving Human Exposure Estimates to NO2 and PM2.5 in an Urban Setting.

Smith JD, Mitsakou C, Kitwiroon N, Barratt BM, Walton HA, Taylor JG, Anderson HR, Kelly FJ, Beevers SD.

Environ Sci Technol. 2016 Nov 1;50(21):11760-11768. Epub 2016 Oct 21.

14.

Synthesis of Xylitan Derivatives and Preliminary Evaluation of in Vitro Trypanocidal Activity.

Elias PR, Coelho GS, Xavier VF, Sales Junior PA, Romanha AJ, Murta SM, Carneiro CM, Camilo NS, Hilário FF, Taylor JG.

Molecules. 2016 Oct 10;21(10). pii: E1342.

15.

Quorum Quenching and Microbial Control through Phenolic Extract of Eugenia Uniflora Fruits.

Rodrigues AC, Zola FG, Ávila Oliveira B, Sacramento NT, da Silva ER, Bertoldi MC, Taylor JG, Pinto UM.

J Food Sci. 2016 Oct;81(10):M2538-M2544. doi: 10.1111/1750-3841.13431. Epub 2016 Sep 7.

PMID:
27603708
16.

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Blackburn DF, Evans CD, Eurich DT, Mansell KD, Jorgenson DJ, Taylor JG, Semchuk WM, Shevchuk YM, Remillard AJ, Tran DA, Champagne AP.

Pharmacotherapy. 2016 Oct;36(10):1055-1064. doi: 10.1002/phar.1831. Epub 2016 Sep 25.

PMID:
27581815
17.

Pharmacist-led minor ailment programs: a Canadian perspective.

Taylor JG, Joubert R.

Int J Gen Med. 2016 Aug 10;9:291-302. doi: 10.2147/IJGM.S99540. eCollection 2016. Review.

18.

Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection.

Link JO, Taylor JG, Xu L, Mitchell M, Guo H, Liu H, Kato D, Kirschberg T, Sun J, Squires N, Parrish J, Kellar T, Yang ZY, Yang C, Matles M, Wang Y, Wang K, Cheng G, Tian Y, Mogalian E, Mondou E, Cornpropst M, Perry J, Desai MC.

J Med Chem. 2016 Aug 25;59(16):7696. doi: 10.1021/acs.jmedchem.6b01043. Epub 2016 Aug 16. No abstract available.

PMID:
27529494
19.

Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal.

Taylor JG, Yates TA, Mthethwa M, Tanser F, Abubakar I, Altamirano H.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1155-61. doi: 10.5588/ijtld.16.0085.

20.

GS-9857 in patients with chronic hepatitis C virus genotype 1-4 infection: a randomized, double-blind, dose-ranging phase 1 study.

Rodriguez-Torres M, Glass S, Hill J, Freilich B, Hassman D, Di Bisceglie AM, Taylor JG, Kirby BJ, Dvory-Sobol H, Yang JC, An D, Stamm LM, Brainard DM, Kim S, Krefetz D, Smith W, Marbury T, Lawitz E.

J Viral Hepat. 2016 Aug;23(8):614-22. doi: 10.1111/jvh.12527. Epub 2016 Mar 9.

PMID:
26957110
21.

The transmission of Mycobacterium tuberculosis in high burden settings.

Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, Lipman M, White RG, Cohen T, Cobelens FG, Wood R, Moore DA, Abubakar I.

Lancet Infect Dis. 2016 Feb;16(2):227-38. doi: 10.1016/S1473-3099(15)00499-5. Epub 2016 Jan 26. Review. Erratum in: Lancet Infect Dis. 2016 Mar;16(3):279.

PMID:
26867464
22.

Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia.

Hosokawa K, Muranski P, Feng X, Townsley DM, Liu B, Knickelbein J, Keyvanfar K, Dumitriu B, Ito S, Kajigaya S, Taylor JG 6th, Kaplan MJ, Nussenblatt RB, Barrett AJ, O'Shea J, Young NS.

J Immunol. 2016 Feb 15;196(4):1568-78. doi: 10.4049/jimmunol.1501739. Epub 2016 Jan 13.

23.

Epidermal devices for noninvasive, precise, and continuous mapping of macrovascular and microvascular blood flow.

Webb RC, Ma Y, Krishnan S, Li Y, Yoon S, Guo X, Feng X, Shi Y, Seidel M, Cho NH, Kurniawan J, Ahad J, Sheth N, Kim J, Taylor JG 6th, Darlington T, Chang K, Huang W, Ayers J, Gruebele A, Pielak RM, Slepian MJ, Huang Y, Gorbach AM, Rogers JA.

Sci Adv. 2015 Oct 30;1(9):e1500701. doi: 10.1126/sciadv.1500701. eCollection 2015 Oct.

24.

Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia.

Fitzhugh CD, Hsieh MM, Allen D, Coles WA, Seamon C, Ring M, Zhao X, Minniti CP, Rodgers GP, Schechter AN, Tisdale JF, Taylor JG 6th.

PLoS One. 2015 Nov 17;10(11):e0141706. doi: 10.1371/journal.pone.0141706. eCollection 2015.

25.

Identification of novel microRNA signatures linked to acquired aplastic anemia.

Hosokawa K, Muranski P, Feng X, Keyvanfar K, Townsley DM, Dumitriu B, Chen J, Kajigaya S, Taylor JG, Hourigan CS, Barrett AJ, Young NS.

Haematologica. 2015 Dec;100(12):1534-45. doi: 10.3324/haematol.2015.126128. Epub 2015 Sep 9.

26.

Liver injury is associated with mortality in sickle cell disease.

Feld JJ, Kato GJ, Koh C, Shields T, Hildesheim M, Kleiner DE, Taylor JG 6th, Sandler NG, Douek D, Haynes-Williams V, Nichols JS, Hoofnagle JH, Jake Liang T, Gladwin MT, Heller T.

Aliment Pharmacol Ther. 2015 Oct;42(7):912-21. doi: 10.1111/apt.13347. Epub 2015 Aug 3.

27.

Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Taylor JG, Gribben JG.

Semin Cancer Biol. 2015 Oct;34:36-45. doi: 10.1016/j.semcancer.2015.07.004. Epub 2015 Jul 29. Review.

28.

The role of the tumor microenvironment in HIV-associated lymphomas.

Taylor JG, Liapis K, Gribben JG.

Biomark Med. 2015;9(5):473-82. doi: 10.2217/bmm.15.13. Review.

29.

Determination of formaldehyde in hair creams by gas chromatography-mass spectrometry.

Lobo FA, Santos TM, Vieira KM, Osório VM, Taylor JG.

Drug Test Anal. 2015 Sep;7(9):848-52. doi: 10.1002/dta.1808. Epub 2015 Apr 29. No abstract available.

PMID:
25929824
30.

Visualizing hypothalamic network dynamics for appetitive and consummatory behaviors.

Jennings JH, Ung RL, Resendez SL, Stamatakis AM, Taylor JG, Huang J, Veleta K, Kantak PA, Aita M, Shilling-Scrivo K, Ramakrishnan C, Deisseroth K, Otte S, Stuber GD.

Cell. 2015 Jan 29;160(3):516-27. doi: 10.1016/j.cell.2014.12.026.

31.

Synthesis and anti-Trypanosoma cruzi activity of diaryldiazepines.

Menezes JC, Vaz LB, de Abreu Vieira PM, da Silva Fonseca K, Carneiro CM, Taylor JG.

Molecules. 2014 Dec 23;20(1):43-51. doi: 10.3390/molecules20010043.

32.

Iron, inflammation, and early death in adults with sickle cell disease.

van Beers EJ, Yang Y, Raghavachari N, Tian X, Allen DT, Nichols JS, Mendelsohn L, Nekhai S, Gordeuk VR, Taylor JG 6th, Kato GJ.

Circ Res. 2015 Jan 16;116(2):298-306. doi: 10.1161/CIRCRESAHA.116.304577. Epub 2014 Nov 6.

33.

Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide.

Baird JH, Minniti CP, Lee JM, Tian X, Wu C, Jackson M, Alam S, Taylor JG 6th, Kato GJ.

Br J Haematol. 2015 Mar;168(5):737-46. doi: 10.1111/bjh.13203. Epub 2014 Nov 6.

34.

Sleep disturbance, depression and pain in adults with sickle cell disease.

Wallen GR, Minniti CP, Krumlauf M, Eckes E, Allen D, Oguhebe A, Seamon C, Darbari DS, Hildesheim M, Yang L, Schulden JD, Kato GJ, Taylor JG 6th.

BMC Psychiatry. 2014 Jul 21;14:207. doi: 10.1186/1471-244X-14-207.

35.

Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF; walk-PHaSST Investigators and Patients.

PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.

36.

Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Krüppel-like factor.

Wang X, Mendelsohn L, Rogers H, Leitman S, Raghavachari N, Yang Y, Yau YY, Tallack M, Perkins A, Taylor JG 6th, Noguchi CT, Kato GJ.

Blood. 2014 Aug 7;124(6):946-54. doi: 10.1182/blood-2013-11-539718. Epub 2014 Jun 10.

37.

Prediction of fetal hemoglobin in sickle cell anemia using an ensemble of genetic risk prediction models.

Milton JN, Gordeuk VR, Taylor JG 6th, Gladwin MT, Steinberg MH, Sebastiani P.

Circ Cardiovasc Genet. 2014 Apr;7(2):110-5. doi: 10.1161/CIRCGENETICS.113.000387. Epub 2014 Mar 1.

38.

Alpha-thalassaemia and response to hydroxyurea in sickle cell anaemia.

Darbari DS, Nouraie M, Taylor JG, Brugnara C, Castro O, Ballas SK.

Eur J Haematol. 2014 Apr;92(4):341-5. doi: 10.1111/ejh.12245. Epub 2014 Jan 30.

39.

Discovery of ledipasvir (GS-5885): a potent, once-daily oral NS5A inhibitor for the treatment of hepatitis C virus infection.

Link JO, Taylor JG, Xu L, Mitchell M, Guo H, Liu H, Kato D, Kirschberg T, Sun J, Squires N, Parrish J, Kellar T, Yang ZY, Yang C, Matles M, Wang Y, Wang K, Cheng G, Tian Y, Mogalian E, Mondou E, Cornpropst M, Perry J, Desai MC.

J Med Chem. 2014 Mar 13;57(5):2033-46. doi: 10.1021/jm401499g. Epub 2014 Jan 10. Erratum in: J Med Chem. 2016 Aug 25;59(16):7696.

PMID:
24320933
40.

Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study.

Darbari DS, Wang Z, Kwak M, Hildesheim M, Nichols J, Allen D, Seamon C, Peters-Lawrence M, Conrey A, Hall MK, Kato GJ, Taylor JG 6th.

PLoS One. 2013 Nov 5;8(11):e79923. doi: 10.1371/journal.pone.0079923. eCollection 2013.

41.

Ultrathin silicon membranes for wearable dialysis.

Johnson DG, Khire TS, Lyubarskaya YL, Smith KJ, Desormeaux JP, Taylor JG, Gaborski TR, Shestopalov AA, Striemer CC, McGrath JL.

Adv Chronic Kidney Dis. 2013 Nov;20(6):508-15. doi: 10.1053/j.ackd.2013.08.001. Review.

PMID:
24206603
42.

A GCH1 haplotype confers sex-specific susceptibility to pain crises and altered endothelial function in adults with sickle cell anemia.

Belfer I, Youngblood V, Darbari DS, Wang Z, Diaw L, Freeman L, Desai K, Dizon M, Allen D, Cunnington C, Channon KM, Milton J, Hartley SW, Nolan V, Kato GJ, Steinberg MH, Goldman D, Taylor JG 6th.

Am J Hematol. 2014 Feb;89(2):187-93. doi: 10.1002/ajh.23613.

43.

Introduction to next-generation nucleic acid sequencing in cardiovascular disease research.

Diaw L, Youngblood V, Taylor JG 6th.

Methods Mol Biol. 2013;1027:157-79. doi: 10.1007/978-1-60327-369-5_7.

PMID:
23912986
44.

Sequencing PCR-amplified DNA in lipoprotein and cardiovascular disease research.

Youngblood V, Taylor JG 6th.

Methods Mol Biol. 2013;1027:139-55. doi: 10.1007/978-1-60327-369-5_6.

PMID:
23912985
45.

Hemodynamic predictors of mortality in adults with sickle cell disease.

Mehari A, Alam S, Tian X, Cuttica MJ, Barnett CF, Miles G, Xu D, Seamon C, Adams-Graves P, Castro OL, Minniti CP, Sachdev V, Taylor JG 6th, Kato GJ, Machado RF.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):840-7. doi: 10.1164/rccm.201207-1222OC.

46.

Case series: biliary leak after transjugular liver biopsy.

Fricker Z, Levy E, Kleiner D, Taylor JG 6th, Koh C, Holland SM, Heller T.

Am J Gastroenterol. 2013 Jan;108(1):145-7. doi: 10.1038/ajg.2012.352. No abstract available.

PMID:
23287950
47.

Coumarins from free ortho-hydroxy cinnamates by Heck-Matsuda arylations: a scalable total synthesis of (R)-tolterodine.

Barancelli DA, Salles AG Jr, Taylor JG, Correia CR.

Org Lett. 2012 Dec 7;14(23):6036-9. doi: 10.1021/ol302923f. Epub 2012 Nov 28.

PMID:
23190249
48.

Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Nekhai S, Xu M, Foster A, Kasvosve I, Diaz S, Machado RF, Castro OL, Kato GJ, Taylor JG 6th, Gordeuk VR.

Haematologica. 2013 Mar;98(3):455-63. doi: 10.3324/haematol.2012.066530. Epub 2012 Oct 12.

49.

Harnessing genomics to identify environmental determinants of heritable disease.

Yauk CL, Lucas Argueso J, Auerbach SS, Awadalla P, Davis SR, Demarini DM, Douglas GR, Dubrova YE, Elespuru RK, Glover TW, Hales BF, Hurles ME, Klein CB, Lupski JR, Manchester DK, Marchetti F, Montpetit A, Mulvihill JJ, Robaire B, Robbins WA, Rouleau GA, Shaughnessy DT, Somers CM, Taylor JG 6th, Trasler J, Waters MD, Wilson TE, Witt KL, Bishop JB.

Mutat Res. 2013 Jan-Mar;752(1):6-9. doi: 10.1016/j.mrrev.2012.08.002. Epub 2012 Aug 28.

50.

Does the corollary discharge of attention exist?

Taylor JG.

Conscious Cogn. 2012 Mar;21(1):325-39. doi: 10.1016/j.concog.2011.09.018. Epub 2012 Jan 20.

PMID:
22265373

Supplemental Content

Loading ...
Support Center